Wang Rui, Xu Ying, Wu Hong-Li, Li Ying-Bo, Li Yu-Hua, Guo Jia-Bin, Li Xue-Jun
Department of Pharmacology, School of Basic Medical Sciences and State Key Laboratory of Natural & Biomimetic Drugs, Peking University, Beijing 100083, China.
Eur J Pharmacol. 2008 Jan 6;578(1):43-50. doi: 10.1016/j.ejphar.2007.08.045. Epub 2007 Sep 19.
Curcuma longa is a main constituent of many traditional Chinese medicines, such as Xiaoyao-san, used to manage mental disorders effectively. Curcumin is a major active component of C. longa and its antidepressant-like effect has been previously demonstrated in the forced swimming test. The purpose of this study was to explore the possible contribution of serotonin (5-HT) receptors in the behavioral effects induced by curcumin in this animal model of depression. 5-HT was depleted by the tryptophan hydroxylase inhibitor p-chlorophenylalanine (PCPA, 100 mg/kg, i.p.) prior to the administration of curcumin, and the consequent results showed that PCPA blocked the anti-immobility effect of curcumin in forced swimming test, suggesting the involvement of the serotonergic system. Moreover, pre-treatment of pindolol (10 mg/kg, i.p., a beta-adrenoceptors blocker/5-HT(1A/1B) receptor antagonist), 4-(2'-methoxy-phenyl)-1-[2'-(n-2''-pyridinyl)-p-iodobenzamino-]ethyl-piperazine (p-MPPI, 1 mg/kg, s.c., a selective 5-HT(1A) receptor antagonist), or 1-(2-(1-pyrrolyl)-phenoxy)-3-isopropylamino-2-propanol (isamoltane, 2.5 mg/kg, i.p., a 5-HT(1B) receptor antagonist) was found to prevent the effect of curcumin (10 mg/kg) in forced swimming test. On the other hand, a sub-effective dose of curcumin (2.5 mg/kg, p.o.) produced a synergistic effect when given jointly with (+)-8-hydroxy-2-(di-n-propylamino)tetralin, (8-OH-DPAT, 1 mg/kg, i.p., a 5-HT(1A) receptor agonist), anpirtoline (0.25 mg/kg, i.p., a 5-HT(1B) receptor agonist) or ritanserin (4 mg/kg, i.p., a 5-HT(2A/2C) receptor antagonist), but not with ketanserin (5 mg/kg, i.p., a 5-HT(2A/2C) receptor antagonist with higher affinity to 5-HT(2A) receptor) or R(-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI, 1 mg/kg, i.p., a 5-HT(2A) receptor agonist). Taken together, these results indicate that the antidepressant-like effect of curcumin in the forced swimming test is related to serotonergic system and may be mediated by, at least in part, an interaction with 5-HT(1A/1B) and 5-HT(2C) receptors.
姜黄是许多传统中药的主要成分,如逍遥散,可有效治疗精神障碍。姜黄素是姜黄的主要活性成分,其抗抑郁样作用先前已在强迫游泳试验中得到证实。本研究的目的是探讨血清素(5-羟色胺,5-HT)受体在姜黄素诱导的该抑郁症动物模型行为效应中的可能作用。在给予姜黄素之前,用色氨酸羟化酶抑制剂对氯苯丙氨酸(PCPA,100mg/kg,腹腔注射)耗竭5-HT,结果表明PCPA阻断了姜黄素在强迫游泳试验中的抗不动效应,提示血清素能系统参与其中。此外,发现预先给予吲哚洛尔(10mg/kg,腹腔注射,一种β-肾上腺素能受体阻滞剂/5-HT(1A/1B)受体拮抗剂)、4-(2'-甲氧基苯基)-1-[2'-(n-2''-吡啶基)-对碘苯氨基]-乙基哌嗪(p-MPPI,1mg/kg,皮下注射,一种选择性5-HT(1A)受体拮抗剂)或1-(2-(1-吡咯基)-苯氧基)-3-异丙氨基-2-丙醇(异米唑烷,2.5mg/kg,腹腔注射,一种5-HT(1B)受体拮抗剂)可预防姜黄素(10mg/kg)在强迫游泳试验中的作用。另一方面,当与(+)-8-羟基-2-(二正丙基氨基)四氢萘(8-OH-DPAT,1mg/kg,腹腔注射,一种5-HT(1A)受体激动剂)、安匹托林(0.25mg/kg,腹腔注射,一种5-HT(1B)受体激动剂)或利坦色林(4mg/kg,腹腔注射,一种5-HT(2A/2C)受体拮抗剂)联合给药时,亚有效剂量的姜黄素(2.5mg/kg,口服)产生协同效应,但与酮色林(5mg/kg,腹腔注射,一种对5-HT(2A)受体亲和力更高的5-HT(2A/2C)受体拮抗剂)或R(-)-1-(2,5-二甲氧基-4-碘苯基)-2-氨基丙烷(DOI,1mg/kg,腹腔注射,一种5-HT(2A)受体激动剂)联合给药时则无此效应。综上所述,这些结果表明姜黄素在强迫游泳试验中的抗抑郁样作用与血清素能系统有关,并且可能至少部分地由与5-HT(1A/1B)和5-HT(2C)受体的相互作用介导。